Item 7A. Quantitative and Qualitative Disclosures About Market Risk
6K characters. Original on sec.gov · Markdown
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risks as well as changes in foreign currency exchange rates as measured against the U.S.
dollar and each other, and changes to the credit markets.
We attempt to minimize these risks by primarily using
foreign currency forward contracts and by maintaining counter-party credit limits.
These hedging activities provide
only limited protection against currency exchange and credit risks.
Factors that could influence the effectiveness of
our hedging programs include currency markets and availability of hedging
instruments and liquidity of the credit
markets.
All foreign currency forward contracts that we enter into are components
of hedging programs and are
entered into for the sole purpose of hedging an existing or anticipated
currency exposure.
We do not enter into such
contracts for speculative purposes and we manage our credit risks by diversifying
our investments, maintaining a
strong balance sheet and having multiple sources of capital.
Foreign Currency Agreements
The value of certain foreign currencies as compared to the U.S. dollar
and the value of certain underlying functional
currencies of the Company, including its foreign subsidiaries, may affect our financial results.
Fluctuations in
exchange rates may positively or negatively affect our revenues, gross margins, operating expenses
and retained
earnings, all of which are
expressed in U.S. dollars.
Where we deem it prudent, we engage in hedging programs
using primarily foreign currency forward contracts aimed at limiting
the impact of foreign currency exchange rate
fluctuations on earnings.
We purchase short-term (i.e., generally 18 months or less) foreign currency forward
contracts to protect against currency exchange risks associated with intercompany
loans due from our international
subsidiaries and the payment of merchandise purchases to foreign
suppliers.
We do not hedge the translation of
foreign currency profits into U.S. dollars, as we regard this as an accounting
exposure, not an economic
exposure.
A hypothetical 5% change in the average value of the U.S. dollar
in 2022 compared to foreign currencies
would have changed our 2022 reported Net income attributable to Henry
Schein, Inc. by approximately $7 million.
As of December 31, 2022, we had forward foreign currency exchange
agreements, which expire through November
16, 2023, with a fair value of $23 million as determined by quoted market
prices.
Included in the forward foreign
currency exchange agreements, Henry Schein, Inc. had net investment
designated EUR/USD forward contracts
with notional values of approximately €200 million, with a reported fair value
of these contracts of $20 million.
A
5% increase in the value of the Euro to the USD from December 31, 2022,
with all other variables held constant,
would have had an unfavorable effect on the fair value of these forward contracts
by decreasing the value of these
instruments by $10 million.
Total
Return Swaps
On March 20, 2020, we entered into a total return swap for the purpose
of economically hedging our unfunded non-
qualified supplemental retirement plan (“SERP”) and our deferred compensation
plan (“DCP”).
This swap will
offset changes in our SERP and DCP liabilities.
At the inception, the notional value of the investments in these
plans was $43 million.
At December 31, 2022, the notional value of the investments
in these plans was $78
million.
At December 31, 2022, the financing blended rate for
this swap was based on LIBOR of 4.03% plus
0.55%, for a combined rate of 4.58%.
For the years ended December 31, 2022 ended and December
25, 2021, we
have recorded a gain/(loss), within the selling, general and administrative
line item in our consolidated statement of
income, of approximately $(17) million and $12 million, respectively, net of transaction costs, related to this
undesignated swap.
This swap is expected to be renewed on an annual basis after its current
expiration date of
March 31, 2023, and is expected to result in a neutral impact to our results
of operations.
Short-Term Investments
We limit our credit risk with respect to our cash equivalents, short-term investments and derivative instruments, by
monitoring the credit worthiness of the financial institutions who are
the counterparties to such financial
instruments.
As a risk management policy, we limit the amount of credit exposure by diversifying and utilizing
numerous investment grade counterparties.
Variable
Interest Rate Debt
As of December 31, 2022, we had variable interest rate exposure for certain
of our revolving credit facilities and
our U.S. trade accounts receivable securitization.
Our revolving credit facility which we entered into on August 20, 2021
and expires on August 20, 2026, has an
interest rate that is based on the U.S. Dollar LIBOR plus a spread based on
our leverage ratio at the end of each
financial reporting quarter.
As of December 31, 2022, there was $0 million outstanding under this
revolving credit
facility.
During the year ended December 31, 2022, we had no borrowings under
this revolving credit facility.
Our U.S trade accounts receivable securitization, which we entered
into on April 17, 2013 and expires on
December 15, 2025, has an interest rate that is based upon the asset-backed
commercial paper rate.
As of
December 31, 2022, the commercial paper rate was 4.58% plus 0.75%,
for a combined rate of 5.33%.
At
December 31, 2022 the outstanding balance was $330 million under
this securitization facility.
During the year
ended December 31, 2022, the average outstanding balance under this securitization
facility was approximately
$166 million.
Based upon our average outstanding balance for this securitization
facility, for each hypothetical
increase of 25 basis points, our interest expense thereunder would have
increased by $0.4 million.
Previous: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of · Next: Item 8. Financial Statements and Supplementary Data